Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05715086 · ClinicalTrials.gov registry record · NA
UPURS Trial for Patient-centered Management of Symptomatic Obstructing Stones
A NA study of Ureteral Stone, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05715086 is a NA study of Ureteral Stone that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 100 participants, below the 167-participant average among 3 other Ureteral Stone trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05715086, a NA study of Ureteral Stone, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective, non-blinded, randomized controlled trial studying the management of symptomatic ureteral stones. This study will compare upfront ureteroscopy vs observation and delayed intervention for patients presenting to the emergency department with a symptomatic ureteral stone.
Conditions Studied
Interventions
- PROCEDURE Ureteroscopy
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-08-23 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05715086
The ClinicalTrials.gov registry entry for NCT05715086 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 167-participant average among 3 other Ureteral Stone trials with a reported enrollment target (40% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ureteral Stone appearing as the primary indexed condition, and to 1 intervention - of which Ureteroscopy is the first listed.
NCT05715086 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05715086 about?
NCT05715086 is a clinical study titled "UPURS Trial for Patient-centered Management of Symptomatic Obstructing Stones". A prospective, non-blinded, randomized controlled trial studying the management of symptomatic ureteral stones. This study will compare upfront ureteroscopy vs observation and delayed intervention for patients presenting to the emergency department with a symptomatic ureteral stone.
What is the current status of trial NCT05715086?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-08-23. Estimated completion is 2026-06-30.
What conditions does trial NCT05715086 study?
This clinical trial studies the following conditions: Ureteral Stone.
What interventions are being tested in trial NCT05715086?
The interventions under investigation include: Ureteroscopy (PROCEDURE).
Who is sponsoring clinical trial NCT05715086?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05715086 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ureteral Stone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.